Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2026-01-04 @ 6:43 AM
Study NCT ID:
NCT04811703
Status:
RECRUITING
Last Update Posted:
2024-09-19
First Post:
2021-03-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer
Sponsor:
Hospices Civils de Lyon
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Ovarian Carcinoma | View |
| None | Peritoneal Carcinomatosis | View |
| None | Stage III Ovarian Cancer | View |
| None | Stage IV Ovarian Cancer | View |
| None | Stage III Fallopian Tube Cancer | View |
| None | Stage IV Fallopian Tube Cancer | View |
| None | Metastatic Malignant Neoplasm in the Peritoneum | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Dose escalation | View |
| None | Phase I study | View |
| None | Intravenous Chemotherapy | View |
| None | Intraperitoneal chemotherapy | View |
| None | PIPAC | View |
| None | RP2D | View |
| None | cytoreductive surgery | View |
| None | Ovarian epithelial cancer | View |
| None | peritoneal cancer | View |
| None | doxorubicin | View |
| None | cisplatin | View |
| None | CA-125 antigen | View |
| None | pharmacokinetic | View |